PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 9, 2014Journal of Clinical Investigation70 citationsOpen Access

5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy

DCDanos C. ChristodoulouHWHiroko WakimotoKOKenji Onoue

Key Result

5'RNA-Seq identified 92 genes with altered start-site usage in a mouse model of hypertrophic cardiomyopathy compared to wild-type mice, including Fhl1, whose genetic ablation was deleterious.

Structured PICO

P
Population
Mouse model of hypertrophic cardiomyopathy (HCM), wild-type (WT) mice, and humans with genetic or acquired cardiomyopathies.
I
Intervention
5'RNA-Seq methodology to detect genome-wide changes in start-site usage; genetic ablation of Fhl1 in HCM mice.
C
Comparator
Wild-type (WT) mice.
O
Outcome
Genome-wide changes in 5' start-site usage and the phenotypic effect of Fhl1 ablation in HCM mice.surrogate

5'RNA-Seq identifies altered transcriptional regulation of Fhl1 as a protective response in hypertrophic cardiomyopathy, suggesting a potential mechanism for gender differences in disease severity.

Abstract

The transcriptome is subject to multiple changes during pathogenesis, including the use of alternate 5' start-sites that can affect transcription levels and output. Current RNA sequencing techniques can assess mRNA levels, but do not robustly detect changes in 5' start-site use. Here, we developed a transcriptome sequencing strategy that detects genome-wide changes in start-site usage (5'RNA-Seq) and applied this methodology to identify regulatory events that occur in hypertrophic cardiomyopathy (HCM). Compared with transcripts from WT mice, 92 genes had altered start-site usage in a mouse model of HCM, including four-and-a-half LIM domains protein 1 (Fhl1). HCM-induced altered transcriptional regulation of Fhl1 resulted in robust myocyte expression of a distinct protein isoform, a response that was conserved in humans with genetic or acquired cardiomyopathies. Genetic ablation of Fhl1 in HCM mice was deleterious, which suggests that Fhl1 transcriptional changes provide salutary effects on stressed myocytes in this disease. Because Fhl1 is a chromosome X-encoded gene, stress-induced changes in its transcription may contribute to gender differences in the clinical severity of HCM. Our findings indicate that 5'RNA-Seq has the potential to identify genome-wide changes in 5' start-site usage that are associated with pathogenic phenotypes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Christodoulou et al. (2014) studied Hypertrophic cardiomyopathy (HCM). 5'RNA-Seq vs. WT mice was evaluated on Altered start-site usage. 5'RNA-Seq identified 92 genes with altered start-site usage in a mouse model of hypertrophic cardiomyopathy compared to wild-type mice, including Fhl1, whose genetic ablation was deleterious.

synapsesocial.com/papers/6a08db2b02034f20cae4ab9bhttps://doi.org/10.1172/jci70108
Ask AI
Helpful
Bookmark
Share
View Full Paper